Chronic Hand Eczema Clinical Trials

22 clinical trials for Chronic Hand Eczema across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream — RECRUITING
• Characterization of Chronic Hand Eczema — RECRUITING
• Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers — RECRUITING
• Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) — COMPLETED · PHASE4
• PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry — NOT_YET_RECRUITING
• Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema — COMPLETED · PHASE3
• Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema — COMPLETED · PHASE2
• Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy — COMPLETED · PHASE2
• A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema — COMPLETED · PHASE3
• A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema — COMPLETED · PHASE3
• Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2) — COMPLETED · PHASE3
• Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema — COMPLETED · PHASE3
• Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials — COMPLETED · PHASE3
• Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema — COMPLETED · PHASE1
• Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema — COMPLETED · PHASE2
• A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety deucravacitinib in patients with chronic hand eczema — OTHER · PHASE2
• Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids — COMPLETED · PHASE2
• Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema — COMPLETED · PHASE1
• Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema — WITHDRAWN
• Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2 — WITHDRAWN · PHASE3
• Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan — COMPLETED · PHASE4
• Chronic Hand Eczema - Self-management and Prognosis — COMPLETED · NA

Refine this search